ColinHowdenMD
Gastroenterology • Memphis, TNEsophagus Disease, Gastrointestinal Functional & Motility Disorders
Professor in Medicine-Gastroenterology and Hepatology, Northwestern University Medical School
Dr. Howden is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
877 Jefferson Ave
Memphis, TN 38103Phone+1 901-545-6969Fax+1 901-545-7306
Education & Training
University of Glasgow Faculty of MedicineClass of 1978
Certifications & Licensure
TN State Medical License 2014 - 2026
IL State Medical License 1998 - 2017
SC State Medical License 1994 - 2000- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Fellow (AGAF) American Gastroenterological Association, 2007
- Super Doctor SuperDoctors.com
- Join now to see all
Clinical Trials
- Functional Dyspepsia Treatment Trial Start of enrollment: 2006 Oct 01
Publications & Presentations
PubMed
- Influence of patient characteristics oneradication with Vonoprazan: A subgroup analysis of the pHalcon-HP trial.William D Chey, Francis Mégraud, Loren Laine, Neila Smith, Eckhard Leifke
JGH Open. 2024-11-01 - Mathematical model of the relationship between pH holding time and erosive esophagitis healing rates.Colin W Howden, Carmelo Scarpignato, Eckhard Leifke, Darcy J Mulford, Gezim Lahu
CPT. 2024-09-19 - 22 citationsACG Clinical Guideline: Treatment of Helicobacter pylori Infection.William D Chey, Colin W Howden, Steven F Moss, Douglas R Morgan, Katarina B Greer
The American Journal of Gastroenterology. 2024-09-01
Journal Articles
- H. Pylori and Barrett’s Esophagus: Implications for Populations and PracticeColin Howden, MD, Nature
- Correction: ACG Clinical Guideline: Treatment of Helicobacter Pylori InfectionColin W Howden, Steven F Moss, Nature
Press Mentions
RedHill's Talicia® Listed as First-Line Choice for H. Pylori in New American College of Gastroenterology GuidelinesSeptember 9th, 2024- FDA Approves New GERD Treatment Vonoprazan for Heartburn ReliefJuly 25th, 2024
- RedHill Biopharma Presents New Talicia and Movantik Data Analyses at ACG 2021October 25th, 2021
- Join now to see all
Professional Memberships
- Fellow
- Fellow
- Member
- British Society of GastroenterologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
